“The health system decides a different kind of technologies that can be used to treat disease, and there are several medical devices available at its cost. But the medical devices have to undergo reviews before it is accessible to physicians, and it is because of the lack of transparency in terms of clinical evidence for the medical device.”
Need for Availability & Access to Clinical Evidence for Medical devices for Europe.
March 11, 20200

Related Articles
March 10, 20200
Pepgra, Scientific and Regulatory CRO Firm, the brand of Guires, UK
Guires, a leading player in the Indian market has recently made an entry into the UK market. Guires has under its aegis a brand ‘Pepgra’, which excl
Read More
March 11, 20200
MIDAS Manchester’s Inward Investment Agency Guires Ltd.
Ganesan A, CEO, Guires Solutions has been invited to participate in a panel discussion on ‘The Digital Opportunity’ organized by MIDAS. Through the
Read More
March 11, 20200
Statswork, Data Science and Analytics division of Guires
Ganesan A - CEO, Guires Ltd UK, is leaving no stone unturned in his attempt to test international waters, after making a successful entry in Manches
Read More

Comment here